The mechanisms of 6-MITC inhibit tumor growth through the disruption of mitochondrial function or the inhibition of the NF-κB pathway by abrogating the PI3K/AKT pathway to induce apoptosis [22,23] and sensitizing the anti-tumor agent to augment cell killing [17]. The gene discussed is AKT1; the disease is neoplasm.